BE873853A - 5-phenyl-2-oxazolecarboximidamides - Google Patents

5-phenyl-2-oxazolecarboximidamides

Info

Publication number
BE873853A
BE873853A BE0/193200A BE193200A BE873853A BE 873853 A BE873853 A BE 873853A BE 0/193200 A BE0/193200 A BE 0/193200A BE 193200 A BE193200 A BE 193200A BE 873853 A BE873853 A BE 873853A
Authority
BE
Belgium
Prior art keywords
oxazolecarboximidamides
phenyl
Prior art date
Application number
BE0/193200A
Other languages
English (en)
Inventor
R White
Original Assignee
Morton Norwich Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morton Norwich Products Inc filed Critical Morton Norwich Products Inc
Publication of BE873853A publication Critical patent/BE873853A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/193200A 1978-02-27 1979-01-31 5-phenyl-2-oxazolecarboximidamides BE873853A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/881,827 US4151168A (en) 1978-02-27 1978-02-27 5-Phenyl-2-oxazole carboximidamides as antidepressants

Publications (1)

Publication Number Publication Date
BE873853A true BE873853A (fr) 1979-07-31

Family

ID=25379300

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/193200A BE873853A (fr) 1978-02-27 1979-01-31 5-phenyl-2-oxazolecarboximidamides

Country Status (15)

Country Link
US (1) US4151168A (fr)
JP (1) JPS54115371A (fr)
AU (1) AU518273B2 (fr)
BE (1) BE873853A (fr)
CA (1) CA1106385A (fr)
CH (1) CH638505A5 (fr)
DE (1) DE2907199A1 (fr)
ES (1) ES477715A1 (fr)
FR (1) FR2418229A1 (fr)
GB (1) GB2014988B (fr)
IE (1) IE47412B1 (fr)
IT (1) IT1115788B (fr)
MX (1) MX5082E (fr)
NL (1) NL190774C (fr)
SE (1) SE430063B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59135008U (ja) * 1983-02-28 1984-09-10 松下電工株式会社 分電盤装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135043C (fr) * 1963-10-11
US3399209A (en) * 1964-12-18 1968-08-27 Monsanto Chem Australia Ltd 2-(2'-oxazolin-2'-yl)-benzimidazoles
FR1537684A (fr) * 1965-12-29 1968-09-07 Monsanto Chem Australia Ltd Procédé de préparation des 2-azolin-2-yl-benzimidazoles

Also Published As

Publication number Publication date
ES477715A1 (es) 1980-04-01
SE7811577L (sv) 1979-08-28
JPS5523827B2 (fr) 1980-06-25
JPS54115371A (en) 1979-09-07
CH638505A5 (de) 1983-09-30
US4151168A (en) 1979-04-24
SE430063B (sv) 1983-10-17
FR2418229B1 (fr) 1983-03-18
CA1106385A (fr) 1981-08-04
IT7947857A0 (it) 1979-02-01
GB2014988B (en) 1982-06-09
NL190774B (nl) 1994-03-16
GB2014988A (en) 1979-09-05
AU4123278A (en) 1979-09-06
MX5082E (es) 1983-03-14
FR2418229A1 (fr) 1979-09-21
AU518273B2 (en) 1981-09-24
DE2907199C2 (fr) 1988-03-24
IE47412B1 (en) 1984-03-07
DE2907199A1 (de) 1979-08-30
NL190774C (nl) 1994-08-16
IT1115788B (it) 1986-02-03
IE782133L (en) 1979-08-27
NL7900239A (nl) 1979-08-29

Similar Documents

Publication Publication Date Title
AT379079B (de) Akupunkturgeraet
BE875475A (fr) Iminoquinazolines
BE872071A (fr) Afdichtorgaan
ATA175779A (de) Hoeschenwindel
AT365922B (de) Netzbett
BE876254A (fr) Omsluitingsinrichting
BE874159A (fr) Thermoplongeur
BE878030A (fr) Snelle informatieschakelaar
BE876344A (fr) Snelkoppelend kogelscharnier
AT374352B (de) Sportschuh
BE876059A (fr) Azolopyrimidinones
BE873461A (fr) Kleerhanger
FI793695A7 (fi) Avskalbar taetningsfoersedd tillslutning foer kaerl
AR218561A1 (es) Copoliester p-oxibenzoilico
BE877468A (fr) Recolteuse-hacheuse
BE879151A (fr) Dubbelwerkende vrijloop
BE877955A (fr) Alkylthiophenoxyalkylamines
ATA872778A (de) Uhrband
AT368010B (de) Rollskier
BE875799A (fr) N-alkenylmoranolines
TR20531A (tr) Karbamoyl oksimiler
BE878212A (fr) Dosismeter
BE871213R (fr) Arylmalonamido-1-oxadethiacephalosporines
AT355471B (de) Schipresse
AR224881A1 (es) 2-hidroxifenilbenzotiazoles

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: NORWICH EATON PHARMACEUTICALS INC.

Effective date: 19990131